Frontline Maintenance Therapy With PARPi is the Standard of Care in Ovarian Cancer

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Frontline Maintenance Therapy With PARPi is the Standard of Care in Ovarian Cancer

By GOG Foundation FEATURING Kathleen Moore

505 views

January 22, 2020

0 Comments

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Feat. M. Raza Mirza

06:47

UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang

06:50

Fengting Yan

Year in Review: Ovarian Cancer

25:10

Yale School of Medicine

Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …

Feat. M. Minkin, E. Ratner

06:23

Total Health

Recent Highlights in Ovarian Cancer

Feat. B. Slomovitz

18:16

Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "Antibody-Drug Conjugates in Ovarian Cancer…

Feat. J. Kurtz

05:09

Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "Final OS Data of Relacorilant, a Selective …

Feat. N. Colombo

23:35

Kathleen Moore

How to Select the Best Maintenance Treatment in Patients With Ovaria…

09:42

Erin Crane

Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer

17:06

Ovarian Cancer Midwest Focus, University of Minnesota

Novel ADCs in Ovarian Cancer: A New Treatment Modality

Feat. S. Lheureux

08:37

Fred Hutchinson Cancer Center

Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer: D…

Feat. K. Banda

24:12

Jubilee Brown

Rare Ovarian Cancer: Epithelial Tumors

08:19

Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "Final OS and Long-Term Safety in the ENGOT…

Feat. M. Raza Mirza

13:58

ISCO - International School of Clinical Oncology

Novel Therapies and Combinations in Ovarian Cancer

Feat. A. Leary

28:26

Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

The Role of Immunotherapy and Targeted Therapy in GYN Cancers

Feat. S. Gaillard

18:57

ESMO 2022 Conference Coverage

ESMO 2022: Should All Advanced Ovarian Cancer Patients Receive a PAR…

Feat. D. Tan

11:32

SGO 2023 Conference Coverage on VuMedi

SGO 2023 GOG 3026 Phase II Trial of Letrozole + Ribociclib in Women …

Feat. B. Slomovitz

13:04

Nebraska Oncology Society

Updates in Ovarian Cancer: Risk Reduction Strategies and Mirvetuxima…

Feat. M. Clark

17:33

AstraZeneca Oncology

First-line Maintenance Therapy for BRCAm Advanced Ovarian Cancer Fol…

Feat. S. Lewin

17:06

2023 Evolution Conference

Genetic Testing in Early and Recurrent Ovarian Cancer

Feat. J. Barr

Login

Login

Join VuMedi

Frontline Maintenance Therapy With PARPi is the Standard of Care in Ovarian Cancer

Related Content